Publications by authors named "Beth Eaby"

Claim this Profile
A
Adjuvant cisplatin and docetaxel for non-small cell lung cancer: the Hospital of the University of Pennsylvania experience.
Jared Weiss, Beth Eaby, James Stevenson, John Kucharczuk, Joel Cooper

J Thorac Oncol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carboplatin/pemetrexed/bevacizumab in the treatment of patients with advanced non-small-cell lung cancer: a single-institution experience.
Binu Malhotra, Tracey Evans, Jared Weiss, Beth Eaby, Susan Stonehouse-Lee

Clin Lung Cancer· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A proposed EGFR inhibitor dermatologic adverse event-specific grading scale from the MASCC skin toxicity study group.
Mario E Lacouture, Michael L Maitland, Siegfried Segaert, Ann Setser, Robert Baran, Beth Eaby

Support Care Cancer· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert consensus on the management of erlotinib-associated cutaneous toxicity in the u.k.
Nicholas Thatcher, Marianne Nicolson, Richard W Groves, Jeremy Steele, Beth Eaby

Oncologist· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Writing for hire: advice for authors (and readers).
Deborah K Mayer, Suzanne M Mahon, Beth Eaby

Clin J Oncol Nurs· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An interdisciplinary consensus on managing skin reactions associated with human epidermal growth factor receptor inhibitors.
Beth Eaby, Ann Culkin, Mario E Lacouture

Clin J Oncol Nurs· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation and psychometric assessment of a short clinical scale to measure chemotherapy-induced nausea and vomiting: the MASCC antiemesis tool.
Alexander Molassiotis, Peter A Coventry, Carrie T Stricker, Caroline Clements, Beth Eaby

J Pain Symptom Manage· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidermal growth factor receptor inhibitor-associated cutaneous toxicities: an evolving paradigm in clinical management.
Thomas J Lynch, Ed S Kim, Beth Eaby, Jody Garey, Dennis P West

Oncologist· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gefitinib in patients with advanced non-small cell lung cancer (NSCLC): the expanded access protocol experience at the University of Pennsylvania.
Maria Luisa Veronese, Kenneth Algazy, Lisa Bearn, Beth Eaby, Jane Alavi

Cancer Invest· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis